Early Oral Carbohydrate Solution vs Clear Liquid Diet in Acute Pancreatitis
NCT07375186 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 276
Last updated 2026-01-29
Summary
Background:
Acute pancreatitis (AP) is an inflammatory condition associated with increased metabolic demands and negative nitrogen balance, making early nutritional support a critical component of management. Concentional practice favored prolonged fasting and delayed oral intake; however, recent evidence supports early oral feeding. Oral carbohydrate solutions (OCS) may provide early caloric support with minimal pancreatic stimulation, but data comparing OCS with clear liquid (CL) diets which is current practice remain limited, particularly in South Asian populations.The Convential diet (CD )group started at liquid diet then progressed towards soft and then solid diet experienced recurring pain at a considerably higher rate than the oral high carbohydrate solution (OCS )group providing essential calories,(13.2% vs. 3.8%, p \< 0.001).OCS showed decrease rate of post prandial recurrent abdominal pain.
Objective:
To compare oral carbohydrate solution versus clear liquid diet as the initial oral feeding strategy in patients with acute pancreatitis, focusing on feeding intolerance and length of hospital stay.
Methods:
This prospective randomized controlled trial will be conducted at a tertiary-care hospital in Lahore, Pakistan. Adult patients (18-70 years) with mild to moderately severe acute pancreatitis will be randomized to receive either an oral carbohydrate solution (10% dextrose in water) or a clear liquid diet as the initial oral feed. The primary outcomes will be feeding intolerance within 24 hours and length of hospital stay. Secondary outcomes include time to successful oral feeding, time to soft diet, changes in pain scores, inflammatory markers (CRP, WBC), glycemic response, need for nutritional escalation, complications, and patient satisfaction. Data will be analyzed using SPSS version 26, with a p-value ≤ 0.05 considered statistically significant.
Conclusion:
If proven safe and effective, oral carbohydrate solution may serve as a simple, cost-effective and well-tolerated alternative to clear liquid diets for early oral feeding in acute pancreatitis, particularly in resource limited settings.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Oral Carbohydrate Solution
Participant will be allocated in oral carbohydrate solution group.Participant will receive an oral carbohydrate solution initiated after clinical stabilization.It will be be administrated orally with volume and frequency standardized for all participants and advancement according to study protocol.
- DIETARY_SUPPLEMENT
-
Clear Liquid diet
Participant will receive a standard clear liquid diet initiated after clinical stabilization as per routine institutional practice in measured frequncy and volume and advancement according to study protocol.
Sponsors & Collaborators
-
Jinnah Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-01
- Primary Completion
- 2027-04-30
- Completion
- 2027-07-31
Countries
- Pakistan
Study Locations
More Related Trials
-
Pneumoperitoneum Management With SurgiQuest AirSeal® at Low vs. Higher Pressure
NCT02837601 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Safety & Efficacy of Synbiotic on the Incidence and Recurrence of Spontaneous Bacterial Peritonitis (SBP) in Cirrhotics
NCT00947336 ·Status: COMPLETED ·Phase: PHASE3
-
Dexmedetomidine Versus Placebo in Endoscopic Retrograde Cholangiopancreatography (ERCP) Sedation
NCT01070680 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine- Propofol Versus Pethidine- Propofol in ERCP
NCT02651792 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
NCT03708458 ·Status: UNKNOWN ·Phase: PHASE4
-
Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01321203 ·Status: COMPLETED
-
Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy
NCT07202559 ·Status: RECRUITING ·Phase: NA
-
Balanced Propofol Sedation Versus Propofol Alone Sedation in Therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01321047 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Deep Analgosedation vs. Endotracheal Intubation General Anesthesia on on Perioperative Sedation Related Adverse Events in Elderly ERCP Patients
NCT07017283 ·Status: RECRUITING ·Phase: NA
-
Pneumoperitoneum Management With SurgiQuest AirSeal at Low vs. Higher Pressure ( PRESSURE )
NCT02541448 ·Status: COMPLETED ·Phase: NA
-
Cold Water Irrigation Therapy as an Adjunct to Indomethacin for Post-Endoscopic Retrograde Cholangiopancreatography(ERCP) Pancreatitis
NCT07330284 ·Status: RECRUITING ·Phase: NA
-
Pain Relief in Laparoscopic Surgery
NCT03867552 ·Status: COMPLETED ·Phase: NA
-
Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP
NCT07333859 ·Status: COMPLETED ·Phase: PHASE4
-
Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)
NCT02111707 ·Status: COMPLETED ·Phase: PHASE4
-
Feasibility Study of a Mobile Health App for Symptom Monitoring in People With Chronic Pancreatitis
NCT05899335 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Enhanced Recovery After Cardiac Surgery
NCT03859102 ·Status: UNKNOWN ·Phase: NA
-
A Study of Serial Magnetic Resonance Cholangiopancreatography (MRCP) Following Morphine-neostigmine and Secretin Provocation in Healthy Volunteers
NCT01134848 ·Status: COMPLETED ·Phase: PHASE4
-
Temporary Application of Abdominal Jackson-Pratt Drain to Reduce Pain After Laparoscopic Surgery in Gynecology
NCT03440086 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
HFNO Versus Nasal CPAP in Obese Patients Undergoing Deep Sedation for ERCP
NCT04912102 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Box Breathing for Anxiety, Pain and Nausea in ERCP Patients
NCT07328477 ·Status: COMPLETED ·Phase: NA
-
Propofol Patient-controlled Sedation for Endoscopic Retrograde Cholangiopancreatography
NCT01505218 ·Status: COMPLETED ·Phase: NA
-
Combined Gastrointestinal Decontamination in Acute Severe Poisoning
NCT07201311 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
CO2 Versus O2 Insufflation During ERCP Depending on Sedation Protocols
NCT01761474 ·Status: COMPLETED
-
High Flow Nasal Cannula in Patients Undergoing ERCP Retrograde Cholangiopancreatography With Intravenous Sedation.
NCT04184089 ·Status: COMPLETED ·Phase: NA
-
Patient-controlled Sedation With Propofol and Remifentanyl for Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01079312 ·Status: COMPLETED ·Phase: PHASE4